ANI Pharmaceuticals | ANIP - Pre Tax Profit


ANI Pharmaceuticals reported $40.22M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
AbbVie USD 7.61B 2.04B Jun/2026
ANI Pharmaceuticals USD 40.22M 8.74M Mar/2026
Aurora Cannabis CAD 11.41M 12.99M Mar/2026
Canopy Growth CAD -157.96M 95.71M Mar/2026
Eli Lilly USD 8.85B 583.8M Mar/2026
Heron Therapeutics USD -2.95M 14.54M Dec/2025
Hikma Pharmaceutical USD 147.5M 3.5M Jun/2025
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Nektar Therapeutics USD -43.09M 8.39M Mar/2026
Novartis USD 3.84B 1.33B Mar/2026
Omeros USD -65.12M 21.27M Jun/2024
Perrigo USD 105.4M 513.9M Jun/2026
Sun Pharmaceuticals INR 35.51B 6.76B Mar/2026
Teva Pharmaceutical Industries USD -455M 1.21B Jun/2026